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*Bacillus intestinalis* strain 1731 is an aerobic, spore-forming, motile, Gram-positive, rod-shaped bacterium that was isolated from the small intestine of a patient with intestinal malignancy. The members of the *Bacillaceae* family are well-known representatives of the human gut microbiota and are implicated in a number of pathologies ([@B1][@B2][@B3]). Using combined culture and genetic workflow, we have previously identified the unexplored diversity of endospore-forming bacteria within humans; this identification necessitated the characterization of spore-forming bacteria, such as *Sporobiota* spp., and the collection of their genes as a sporobiome, owing to their unique common characteristics ([@B4][@B5][@B6]).

The 16S rRNA gene sequences of *B. intestinalis* strain 1731 shared 99% similarity with those of various *Bacillus* strains, including *B. subtilis*, *B. amyloliquefaciens*, and *B. atrophaeus*.

An *in silico* DNA-DNA hybridization (DDH) analysis, using the genome-to-genome distance calculator (GGDC2.1) algorithm, produced a highest DDH value of 50.80%, which indicates that *B. intestinalis* strain 1731 is a new species belonging to the *Bacillus* genus ([@B7]).

The genome of *B. intestinalis* strain 1731 was sequenced using an Illumina HiSeq sequencing platform (GA IIx; Illumina, CA). Library preparation, sequencing, and runs were performed in accordance with the manufacturer's instructions. *De novo* assembly was performed with SPAdes version 3.9.0 ([@B8]), and annotation was performed via the NCBI and RAST servers ([@B9], [@B10]). The final draft genome assembly consisted of 164 contigs and 4,047,276 bp (G+C content of 43.9%), and the total coverage over the genome was 145-fold. It comprises 3,913 gene-coding sequences and 106 predicted RNA genes (86 tRNA, 15 rRNA, and 5 ncRNA genes). Genome analysis using the NCBI and CARD databases revealed genes coding for resistance to the antibiotics tunicamycin, fosfomycin, and bleomycin and class A and B beta-lactamases; the genes *mprF*, *aadK*, and *tmrB* (determinant of resistance to peptide, aminoglycoside, and nucleoside antibiotics, respectively); major facilitator superfamily (MFS) transporters; and the organic hydroperoxide resistance protein OhrA ([@B11]).

The genome contains virulence factors, including hemolysin D, serine protease, zinc metalloprotease HtpX, peptidases, alpha-amylase, amidohydrolase, phospholipase, phenolic acid decarboxylase, and subtilosin A exodeoxyribonuclease III and VII capsular, flagellar, and sporulation proteins ([@B12], [@B13]). In addition, we identified superoxide dismutases that are considered to possess carcinogenic properties in some bacteria ([@B14]).

The availability of the *B. intestinalis* genome sequence facilitates further analysis of human sporobiota and its possible implications in intestinal malignization.
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The complete genome sequence has been deposited in the NCBI database under the accession no. [MWZB00000000](https://www.ncbi.nlm.nih.gov/nuccore/MWZB00000000).
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